REFINE YOUR SEARCH
Type of document
|Date||Ref.||Title||Section||Type||Download||Info||Summary||Related Documents||Translated versions|
|10/11/2016||2016-1563||Issues for consideration in implementing IFRS 9: Financial Instruments||Audit, Corporate Disclosure, IFRS Supervisory Convergence||Statement||PDF
|30/09/2016||2016/1408||ESMA appoints new chairs to Standing Committees||Board of Supervisors, Fund Management, Market Integrity, MiFID - Investor Protection||Statement||PDF
The Board of Supervisors of the European Securities and Markets Authority (ESMA) has appointed the following individuals to serve as chairs of its standing committees:
The standing committees are expert groups drawn from ESMA staff and the national competent authorities for securities markets regulation in the Member States, and are responsible for the development of policy in their respective areas. The appointments are for a period of two years and commence with immediate effect.
|02/06/2016||2016/902||MiFID practices for firms selling financial instruments subject to the BRRD resolution regime||MiFID - Investor Protection||Statement||PDF
|23/02/2021||ESMA22-105-1307||Introductory statement on GameStop share trading- Steven Maijoor||Market Integrity, MiFID - Investor Protection||Statement||PDF
|11/06/2020||ESMA32-334-245||ESMA response to EC Consultation on NFRD||Corporate Disclosure, Sustainable finance||Statement||PDF
|15/07/2021||ESMA32-384-5209||ESMA Public Statement SPACs||MiFID - Investor Protection, Prospectus||Statement||PDF
|12/07/2019||ESMA35-36-1743||Statement Product Intervention||MiFID - Investor Protection||Statement||PDF
|31/03/2020||ESMA35-36-1919||Clarification of issues related to the publication of reports by execution venues and firms as required under RTS 27 and 28||COVID-19, MiFID - Investor Protection||Statement||PDF
|28/06/2017||ESMA35-36-885||Product Intervention- General Statement||Innovation and Products, MiFID - Investor Protection||Statement||PDF
This statement provides an update on the European Securities and Markets Authority’s (ESMA) work in relation to the sale of contracts for differences (CFDs), binary options and other speculative products to retail investors.
ESMA has been concerned about the provision of speculative products such as CFDs, rolling spot forex and binary options to retail investors for a considerable period of time and has conducted ongoing monitoring and supervisory convergence work in this area. In this context, ESMA has previously published a number of Q&As on CFDs and other speculative products to foster supervisory convergence, having established a CFD Task Force in July 2015, and also issued a further investor warning on the sale of CFDs, binary options and other speculative products in July 2016.
However, ESMA remains concerned that these supervisory convergence tools may not be sufficiently effective to ensure that the risks to consumer protection are sufficiently controlled or reduced. ESMA is therefore discussing the possible use of its product intervention powers under Article 40 of MiFIR to address investor protection risks in relation to CFDs, rolling spot forex and binary options.
ESMA is in the process of discussing the possible use of its product intervention powers under Article 40 of MiFIR, the possible content of any such measures, and how they could be applied. However, ESMA can confirm that the measures being discussed for (i) CFDs and rolling spot forex and (ii) binary options include proposals that take into account a number of measures that have been adopted or publicly consulted on by EU National Competent Authorities. These measures include leverage limits, guaranteed limits on client losses, and / or restrictions on the marketing and distribution of these products.
In accordance with Article 40 of MiFIR, any intervention measures must be approved by the ESMA Board of Supervisors and can only come into effect from 3 January 2018 at the earliest.
 ESMA/2016/1166 Warning about CFDs, binary options and other speculative products published 25 July 2016
|19/12/2018||ESMA35-43-1328||Brexit Statement- information to clients||Brexit, MiFID - Investor Protection||Statement||PDF
|20/03/2020||ESMA35-43-2348||ESMA Statement on COVID-19 telephone recording||COVID-19, MiFID - Investor Protection||Statement||PDF
|06/05/2020||ESMA35-43-2391||Reminder of firms’ MiFID II conduct of business obligations in the context of increasing retail investor activity||COVID-19, MiFID - Investor Protection||Statement||PDF
|13/01/2021||ESMA35-43-2509||Reminder to firms of the MiFID II rules on ‘reverse solicitation’ in the context of the recent end of the UK transition period||Brexit, MiFID - Investor Protection||Statement||PDF
|31/03/2021||ESMA35-43-2632||Application of the temporary suspension of the obligation to publish RTS 27 reports||MiFID - Investor Protection||Statement||PDF
|21/07/2021||ESMA35-43-2748||Public statement- Results of the 2020 Common Supervisory Action (CSA) on MiFID II suitability requirements||MiFID - Investor Protection||Statement||PDF
|13/07/2021||ESMA35-43-2749||ESMA Public Statement PFOF and zero-commission brokers||MiFID - Investor Protection||Statement||PDF
|08/07/2022||ESMA35-43-3137||ESMA presents the results of the 2021 Common Supervisory Action (CSA) on MiFID II product governance requirements||MiFID - Investor Protection, Supervisory convergence||Statement||PDF
|10/01/2019||ESMA50-165-731||ESMA annual statistical report on performance and costs of retail investment products in the EU||MiFID - Investor Protection, Risk Analysis & Economics - Markets Infrastructure Investors||Annual Report||PDF
|28/10/2021||ESMA70-154-2780||ESMA’s Statement on Investment Recommendations on Social Media||Market Integrity, MiFID - Investor Protection||Statement||PDF
|17/02/2021||ESMA70-155-11809||Episodes of very high volatility in trading of certain stocks||Market Integrity, MiFID - Investor Protection||Statement||PDF